Committed to
improve outcome in
C3G and IC-MPGN
CompCure brings together patients/caregivers, clinicians, leading multidisciplinary experts, industry partners, and other relevant stakeholder with a shared commitment to improving outcome in C3G and IC-MPGN.
Finding ways for improving outcome of C3G and IC-MPGN
About C3G and IC-MPGN
C3G and IC-MPGN are ultra rare and chronic progressive kidney diseases. They commonly lead to proteinuria, hematuria, hypocomplementemia, hypertension, end-stage kidney disease, and several other severe complications that can affect different organ-systems.
More than half of the patients will reach end stage renal disease (ESRD) 10 years after diagnosis. The diseases recur at a high rate in the allografts after kidney transplantation.
About CompCure
CompCure is a non-profit association that was founded by parents of a girl with IC-MPGN, in collaboration with leading European experts.
The primary goal of CompCure is to improve the outcomes for individuals with C3G and IC-MPGN. This is accomplished by raising awareness of rare kidney diseases, improving the diagnostic rates, generating evidence through research, establishing a comprehensive international registry, promoting the widespread adoption of clinical guidelines, and providing support for the development of new therapies.
CompCure operates through a strong collaboration between patients, physicians, industry partners, and other relevant stakeholders.
About the ERK network and registry
The European Rare Kidney network (ERKnet) is one of 24 rare disease networks financed and supported by the European Union. The ERKnet counts more than 100 specialized units across 24 countries.
The ERKnet has established the European Rare Kidney Registry (ERKreg) which includes data from more than 70.000 patients with rare kidney diseases.
The most recent news
GPN Presentation
Marianne joined the annual GPN (Gesellschaft für Pädiatrische Nephrologie) meeting in Hamburg where she talked about CompCure's main focus and goals to drive awareness about C3G and IC-MPGN. The lecture gave rise to a lot of inspiring and encouraging questions, comments and conversations where people showed interest in and support to CompCure.
World Kidney Day
CompCure joined World Kidney Day on the 14th of March which was a great opportunity to raise awareness on our main focus to secure early diagnosis and appropriate therapeutic interventions for C3G and IC-MPGN.
Rare Disease Day
CompCure took part in Rare Disease Day on the 29th of February to shine the light on the unmet needs of approximately 400 million people around the world who are affected by a rare disease. People involved in CompCure contributed to the video.
It is with pride and humbleness that we can look back at 2023, and recognize the accomplishments achieved by our outstanding team and dedicated collaboration partners. Below you find some highlights, which support our commitment to improve outcome in C3G and IC-MPGN.
A huge thank you to all involved parties, and especially to all the patients and their treating nephrologists for trusting us their data. We would also like to thank our Board, the Steering Committee and the team in Heidelberg for bringing our strategy to life in close partnership with the ERKnet. Last but not least we thank our industry partners for their broad commitment to our community. I am confident, that together we can realize our ambition to build the biggest C3G and IC-MPGN registry globally.
-
The CompCure registry recruited 75 patients in 8 weeks.
-
CompCure was presented by Franz Schaefer at the annual ERK network meeting.
-
CompCure was presented by Franz Schaefer and Marianne Silkjaer Nielsen at the ERA congress.
-
Early diagnosis was discussed by Marina Vivarelli, Marina Noris, Fadi Fakhouri
and Marianne Silkjaer Nielsen and broadcasted on MedScape/WebMd.
-
A poster on CompCure was presented by Giulia Bassanese at the ESPN congress.
-
CompCure was presented at the German and US patient meetings.
-
CompCure was showcased twice at the Escape network meetings.
-
CompCure is expanding globally, e.g. with health institutions in Seoul joining the registry.
-
The awareness rare kidney diseases, incl. C3G and IC-MPGN
has been raised in different medias.
-
An international CompCure patient advocacy committee is currently
being established to give patients a stronger and united voice.
-
CompCure partnered with EKHA with the aim of supporting early diagnosis,
e.g. through implementation of broad screening programs.
We look forward to 2024 where CompCure will continue to work on increasing the understanding of C3G and IC-MPGN, drive early diagnosis, and optimal treatment for the individual patient. The continue to strengthen the awareness of these serious kidney diseases, we are grateful for the support and collaboration with Bent, Sebastian and Anders.
We wish all of you Happy Holidays and all the best for 2024.
The Kidneeds C3G and DDD family conference took place in Iowa from 13-14 Oct 2023.
It was touching and inspiring to connect with patients and families from all over North America, and listen to their journeys and experiences. The needs of C3G and IC-MPGN patients varies significantly, and so does the accessible level of care. In this context, it was encouraging to learn about the high standards of specialized care offered at the university of Iowa, Stead Family Children's hospital by the integrated team of leading clinicians and scientists at the Molecular Otolaryngology and Renal Research Laboratories - MORL.
CompCure was presented as an international initiative driven by a team of leading experts based in Europe. It was reassuring and inspiring to discuss common interests and potential opportunities for collaboration.
25 September is C3G and IC-MPGN awareness day.
In this connection, it was a pleasure to shine the light on C3G, IC-MPGN and aHUS during the annual meeting in the German “Selbsthilfegruppe” in Cologne over the weekend. The event was participated by ~70 patients and caregivers from Germany, Austrua and Switzerland. It was very interesting and touching to listen to the patient’s journeys, the challenges, and to discuss management opportunities now and in the future with experienced nephrologists from leading German treatment centers.
CompCure, and the importance of establishing an international registry was also presented. We are grateful the commitment and support we are also receiving from the patient community.
Getting an early and exact diagnosis with C3G and IC-MPGN is critical to ensure that the right management and therapies are initiated. Yet, the diagnostic journey is long for many patients in our community, and this has negative impact on outcome. One of CompCure’s objectives is to ensure that more patients are getting diagnosed early. This starts with broader awareness about the diseases, and knowledge of what it takes to diagnose them. In the MedScape video, Marina Vivarelli, Marina Noris, Fadi Fakhouri and Marianne Silkjær Nielsen discuss approaches on how to make sure that more patients are being diagnosed early and precisely.
See the movie with log in - register for free, in a few easy steps
During the European Renal Association (ERA) congress in Milan, which took place from 15-18 June 2023, Marianne Silkjær Nielsen had the pleasure of discussing a collaborative approach towards improving outcome in C3G and IC-MPGN with Franz Schaefer and Fadi Fakhouri at the Novartis symposium.
Through our partnership with leading experts, clinicians, patient organizations, pharmaceutical companies and other relevant stakeholders, CompCure will help driving better outcome in C3G and IC-MPGN:
-
The awareness of the diseases will be broadened, also leveraging the
ERKnetwork which counts >100 specialized units from 24 European countries
-
Profound evidence will be generated through a comprehensive international registry
-
Activities to advance science and the development of new therapies will be encouraged and supported.
We are thankful for all the support we are receiving, and we are excited to continue the journey from unmet needs to better outcome in C3G and IC-MPGN.
An update on CompCure was provided by Franz Schafer and Giulia Bassanese at the 7th ERKNet Annual Meeting, which took place in Heidelberg from 9-11th May 2023.
The feedback from participating Nephrologists joining from all over Europe was very positive, and there was broad interest in supporting the initiative.
https://www.erknet.org/events/7th-annual-meeting-impressions
CompCure Kick-off meeting successfully held in Heidelberg on 10 May 2022.